1-4 of 4
Louise Dorn
Close
Sort by
Journal Articles

Significance of, and Difficulty in Diagnosing, Erythropoietin Deficiency in Sickle Cell Anemia

Santosh L Saraf, MD, Seema Sidhwani, DO, Mohammed Farooqui, DO, Giovanni Infusino, MD, Lani Krauz, RN, Michael Gowhari, MD, Stephen Vara, MD, Louise Dorn, RN, MS, Joseph Desimone, PhD, Robert Molokie, MD, Yogen Saunthararajah, MD
Journal: Blood
Blood (2008) 112 (11): 2479.
https://doi.org/10.1182/blood.V112.11.2479.2479
Published: 2008
Journal Articles

Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease

Clinical Trials & Observations
Yogen Saunthararajah, Cheryl A. Hillery, Don Lavelle, Robert Molokie, Louise Dorn, Linda Bressler, Stefana Gavazova, Yi-Hsiang Chen, Ronald Hoffman, Joseph DeSimone
Journal: Blood
Blood (2003) 102 (12): 3865–3870.
https://doi.org/10.1182/blood-2003-05-1738
Published: 2003
Journal Articles

Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia

Clinical Trials & Observations
Joseph DeSimone, Mabel Koshy, Louise Dorn, Donald Lavelle, Linda Bressler, Robert Molokie, Nasrin Talischy
Journal: Blood
Blood (2002) 99 (11): 3905–3908.
https://doi.org/10.1182/blood.V99.11.3905
Published: 2002
Journal Articles

2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia

Clinical Trials & Observations
Mabel Koshy, Louise Dorn, Linda Bressler, Robert Molokie, Donald Lavelle, Nasrin Talischy, Ronald Hoffman, Wendy van Overveld, Joseph DeSimone
Journal: Blood
Blood (2000) 96 (7): 2379–2384.
https://doi.org/10.1182/blood.V96.7.2379
Published: 2000